feed,title,long_url,short_url
SeekingAlpha,Syngene International extends collaboration with Amgen,https://seekingalpha.com/news/3780652,
SeekingAlpha,FDAâ€™s OTAT in agreement pain reduction as primary endpoint in Mesoblast's Phase 3 program,https://seekingalpha.com/news/3780651,
